Assignee
BIOHENG THERAPEUTICS LTD
KY·0 granted patents·7 pending applications·0 citations·filing 2021–2022
Top patents by PatentIndex Score
7 records- 0152US2023399398A1Cd7-targeting humanized antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0252US2023390336A1Chimeric antigen receptor targeting cd7 and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0351US2024018236A1Cd19-targeting humanized antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0451US2024052029A1Ror1-targeting antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0550US2024082306A1Novel chimeric antigen receptor and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0650US2024043532A1Nkg2a-targeting antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0748US2024018251A1Bcma-targeting single-domain antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BIOHENG THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →